Back to Journals » International Journal of General Medicine » Volume 9

An observation on inappropriate probiotic subgroup classifications in the meta-analysis by Lau and Chamberlain
Authors McFarland LV
Received 17 August 2016
Accepted for publication 18 August 2016
Published 30 September 2016 Volume 2016:9 Pages 333—336
DOI https://doi.org/10.2147/IJGM.S119970
Checked for plagiarism Yes
Editor who approved publication: Dr Scott Fraser
Lynne V McFarland
Department of Medicinal Chemistry, University of Washington, Seattle, WA, USA
I read with great interest the systematic review of meta-analysis assessing probiotics for the prevention of Clostridium difficile-associated diarrhea (CDAD) published in the International Journal of General Medicine. These authors pooled 26 randomized controlled trials (RCTs) and concluded that Lactobacilli, mixtures, and Saccharomyces probiotics were effective in preventing CDAD. However, the meta-analysis by Lau and Chamberlain is flawed due to improper classification by the types of probiotics. It is important to recognize that the efficacy of probiotics for various diseases has been shown to be strain specific for each probiotic product, and thus the data should only be pooled for probiotics that are of the identical type. In their analysis of probiotic subgroups by various species, the authors have inappropriately merged different types of Lactobacilli into one subgroup “Lactobacilli” and different types of mixtures into one group classified as “Mix”.
View the original paper by Lau and Chamberlain.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.